Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Abingdon Healt. (ABDX)

Price 9.00p on 08-12-2023 at 17:30:03
Change 0.25p 2.86%
Buy 9.50p
Sell 8.50p
Buy / Sell ABDX Shares
Last Trade: Sell 5,000.00 at 8.8111p
Day's Volume: 83,226
Last Close: 9.00p
Open: 8.75p
Day's Range 8.75p - 9.00p
52wk Range: 3.75p - 16.50p
Market Capitalisation: £11m
VWAP: 9.028632p
Shares in Issue: 122m

Recent Trades History Abingdon Healt. (ABDX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 5,000 8.8111p Ordinary
15:40:05 - 08-Dec-23
Sell* 9,524 8.8111p Ordinary
15:19:44 - 08-Dec-23
Buy* 54,890 9.10p Ordinary
14:23:09 - 08-Dec-23
Buy* 987 9.113p Ordinary
13:39:25 - 08-Dec-23
Buy* 109 9.113p Ordinary
13:38:01 - 08-Dec-23
Buy* 42 9.113p Ordinary
13:37:29 - 08-Dec-23
Buy* 21 9.113p Ordinary
12:06:52 - 08-Dec-23
Buy* 1,626 9.10p Ordinary
12:02:28 - 08-Dec-23
Buy* 5,582 9.10p Ordinary
11:30:49 - 08-Dec-23
Sell* 4,681 8.8111p Ordinary
10:24:35 - 08-Dec-23

Share Price History for Abingdon Healt.

Time period:
Date Open High Low Close Volume

Share News for Abingdon Healt.

UK shareholder meetings calendar - next 7 days

8th Dec 2023 14:54

Read More

Abingdon Health appoints Feather as new interim finance director

24th Oct 2023 13:26

(Alliance News)- Abingdon Health PLC on Tuesday named Andrew Feather as its new interim finance director. Read More

IN BRIEF: Abingdon Health finance chief resigns, seeks interim hire

18th Oct 2023 10:22

Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Chief Financial Officer Melanie Ross resigns as a director of the company with immediate effect and will leave the company outright on November 30. Abingdon Health says it expects to appoint an interim finance director shortly. Read More

Abingdon Health reports narrowed annual loss as shifts away from Covid

17th Oct 2023 11:06

(Alliance News) - Abingdon Health PLC on Tuesday reported a narrowed loss amid higher revenue and decreased costs, as it focuses on shifting away from Covid products. Read More

AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data

17th Oct 2023 10:18

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered